Curated GI articles March 18th, 2022: Healthcare Private Equity Outlook – 2022 and Beyond (Bain & Co.)
Curated GI articles March 18th, 2022:
Healthcare Private Equity Outlook – 2022 and Beyond (Bain & Co.)
Virtual-care company Firefly Health partners with Oshi Health for digital digestive care (Mobi Health News)
As part of the deal, Firefly members receive access to virtual visits with a care team, including providers, dietitians and psychologists.
metaMe Health Raises $2.2 Million to Bring Its IBS Solution to Market (Business Wire)
In the coming months, metaMe’s team will build on this momentum as it prepares for the commercial launch of Regulora, slated for the second half of 2022.
Healthcare Private Equity Outlook: 2022 and Beyond (Bain & Co.)
Healthcare investors who create value—in both health improvements and the financial returns that follow—will be the champions who stand out in the years to come.
Noninvasive Colorectal Cancer Screening Options: Expert Advice (Medscape)
A hybrid approach combining annual fecal immunochemical testing (FIT) at age 45-49, followed by colonoscopy between ages 50 and 70, could result in substantial gains in life-years.
‘Know thyself’: One gastroenterologist’s answer to avoiding burnout (Becker’s GI & Endoscopy)
Ben Bradenham Jr., MD, a gastroenterologist at Gastrointestinal Specialists in Richmond, Va., joined Becker’s to discuss how physician education is failing in attempts to counter burnout.
Medtronic’s colonoscopy AI cuts number of missed polyps in half, study finds (Fierce Biotech)
Findings published in ‘Gastroenterology’ show that AI technology-assisted coloscopy improves the accuracy of polyp detection, which plays an important role in the prevention of CRC.
From Point-of-Care to At-Home Breath Testing: A GI Community Fireside Chat with Dr. Ziad Gellad
Dr. Ziad Gellad (Duke University School of Medicine) discusses his experience shifting from a point-of-care breath test model to at-home breath testing during the pandemic.
American Cancer Society projects 52,280 CRC deaths in 2022: 7 notes (Becker’s GI & Endoscopy)
CRC, the third leading cause of cancer-related deaths in men and in women, is projected to cause 52,280 deaths this year, according to the American Cancer Society.
Three Trials From ASCO GI Renew Hope for Successful Treatment of Difficult GI Cancers (Medscape)
Mark Lewis, MD, director of gastrointestinal (GI) oncology at Intermountain Healthcare in Salt Lake City, Utah, summarizes takeaway points from the 2022 ASCO GI Cancers Symposium.
Aasma Shaukat, MD, MPH on role as an advisor for Iterative Scopes, physician roles in the industry, and advice for healthtech entrepreneurs (GI StartUp Podcast)
In this podcast, Asma Shaukat, MD, MP speaks about her role as an advisor for iterative scopes, the benefits and pitfalls of physician engagement with the industry and her take on those rules of engagement.
Molecular signature of microorganisms in stool samples could predict pancreatic cancer risk (News-Medical)
A patent has been applied to develop a pancreatic cancer diagnostic kit that detects microbial genomes in stool samples in a rapid, non-invasive, and affordable way.
Endiatx’s pill-sized robot sees and swims inside the stomach (Medical Design & Outsourcing)
Endiatx plans to seek FDA clearance for PillBot as a Class II medical device based on prior approvals of AnX Robotica’s magnetic NaviCam and Medtronic’s PillCam.
What’s driving the next generation of physicians to private practice? (Becker’s ASC Review)
Between rising costs, physician burnout and increasing consolidation, physicians are increasingly choosing hospital employment over private practice.
Endoscopic balloon dilation safe, provides longer symptom-free survival in CD stenosis (Healio)
Endoscopic balloon dilation was more effective than fully covered self-expandable metal stents for Crohn’s disease strictures, according to a study published in The Lancet GI & Hepatology.
Distant-Stage Colorectal Adenocarcinoma Rising In Younger People (GI & Endoscopy News)
Rates of metastatic colorectal adenocarcinomas are increasing fastest among people 20 to 54 years of age, most notably in people under age 40.
Deciphering gut microbiome ‘chatter’ to combat IBD (Science Daily)
The study deciphers cellular crosstalk to identify how beneficial bacteria communicate with our immune system to treat IBD and reduce gut inflammation.
HIMSS 2022: Retail, primary care disruptors are hungry for partnerships with traditional providers (Fierce Healthcare)
Major retail and primary care players are adamant that their success depends on playing nice with traditional care delivery organizations.
Technologies playing a major role in transforming gastroenterology (Med Tech Outlook)
Wearable gadget technology is gaining popularity and is used in the field of GI to diagnose, manage and possibly prevent GI disorders.
More Hot headlines in GI
Registry data support lowering CRC screening age to 45 (MDedge)
Register for the 2022 AGA Tech Summit (AGA)
Guardant wins new clearances in Japan for liquid biopsy test (Lab Pulse)
Cryoballoon ablation demonstrates long-term durability in BE (Mdedge)
InTandem launches Vivo Infusion via two-part deal (Axios)
No Medicare Payment Hike Needed for Docs in 2023, MedPAC Says (Medpage Today)
Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham-controlled trial (BMJ)
Overweight Individuals With NAFLD Cirrhosis Fare Better Pre-, Post-Liver Transplant
(GI & Endoscopy News)
Colonoscopies save lives, but many Americans don’t get one (The Philadelphia Inquirer)
Videos: Interviews with GI Leaders (NextServices)